Nanotech Achieves 1st Roll-to-Roll Commercial Scale Production Run

Posted on by

VANCOUVER, BRITISH COLUMBIA--(Marketwire -07/09/12)- Nanotech Security Corp. (the "Company") (NTS.V) is pleased to announce that the Company has successfully completed its first large scale test-run using its nanotechnology-based optical security feature, NOtES. An independent third party was contracted to conduct a production test-run embossing images onto a 300 metre (1000 ft) PET transparent plastic film. The third party is a multi-billion dollar world leader in optical products. The approximately 27cm (10.5 in) wide film was run on a continuous roll-to-roll basis over the entire length and comprises 8 columns of optical images arrayed in rows with some images being continuous, and others which are separated by .5 cm spacing. Over every 27 sq. centimeters there are some 23 separate and clearly visible nanotechnology- based optical images embossed onto the plastic substrate. Of the 8 columns, 2 columns were single continuous images over the full 300 metre length demonstrating common pre-requisites for potential bank note applications.

The production run shows that the Company's origination process and master shims used by the third parties embossing equipment were able to transfer separate and continuous images accurately onto the film over a commercial scale run. The technology proved to be extremely robust in the high-volume, high-speed setting - with the last ten metres performing as strongly as the first ten metres. Images of this film which represents a revolutionary optical-tagging system will be available in the near future on the Company's website at http://www.nanosecurity.ca/press_imagesvideos.php.

Doug Blakeway commented, "We are very pleased by the results of this test which demonstrated the technical feasibility of using the Company's patent-pending, highly advanced nano-hole optical technology in a large scale commercial application. The plastic film test-run was imprinted with over 150,000 separate and easily visible iridescent optical images which, once the production run was set up, were produced in a matter of minutes. This technical proof-of-concept is a major breakthrough for the Company's scientific team and we look forward to sharing our developments with the many potential users who are keenly following our progress."

About Nanotech Security Corp.:

With a nearly 30 year history in security applications for law enforcement, Nanotech Security Corp. licensed nanotechnology which originated at Simon Fraser University in order to try to develop products to sell into the authentication and anti-counterfeiting market. The technology uses patented algorithms with electron and ion beam technology to fabricate hundreds of millions of nano-holes into a wide variety of materials. These nano-holes can be arrayed into unique patterns which employ the surface plasmonic physics of light waves to collect and reflect concentrated light in readily visible images somewhat similar to holograms but with certain superior technical and commercial aspects. The technology allows images which are visible to the naked eye as well as so-called covert features which are readable only by machine. The company is working to enhance security for banknotes but other potential commercial applications include authenticating legal documents, designer merchandise, concert tickets, tax-paid stamps, medical & credit cards, government documents, passports, and pharmaceuticals. More information on the company can be found at http://www.nanosecurity.ca.

This news release contains forward looking information or statements. Investors are cautioned that such forward-looking statements involve risks and uncertainties including, the risk that commercial products using the nano-technology will never be successfully developed, the need for unknown amounts of additional capital that will dilute shareholders if it is available at all (for which there can be no certainty). Investors are cautioned that any such forward looking statements are not guarantees for future performance and the actual results or developments may differ materially from those suggested in such statements. For more information on the Company, investors should review the Company's home jurisdiction filings that are available at http://www.sedar.com.

THE TSX VENTURE EXCHANGE DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

More:

Nanotech Achieves 1st Roll-to-Roll Commercial Scale Production Run

Researchers use nanotech to make cancer 3M times more detectable

Posted on by

Scientists at Princeton University say they have used nanotechnology to make tests to detect diseases, like cancer and Alzheimer's disease, 3 million times more sensitive.

That means what researchers are calling a breakthrough in nanotechnology and medicine could enable doctors to detect these illnesses at much earlier stages, when they are more treatable.

"This advance opens many new and exciting opportunities ... in disease early detection and treatment," said Stephen Chou, a Princeton engineering professor, who led the research team. "You can have very early detection with our approach."

Princeton researchers used nanotechnology to improve a biological test called an immunoassay, which measures the concentration of a substance in a body fluid sample, and is used to find markers for cancers and Alzheimer's, in patients. The test produces a fluorescent glow when the disease is detected. The stronger the presence of the disease, the brighter the test glows.

However, if only faint, early-stage, traces of the disease are present, the glow can't be detected and the disease could be missed.

The Princeton researchers used nanotechnology to amplify the fluorescence, which gave them a 3-million-fold improvement in detection. It means the test now can detect disease with 3 million times fewer disease biomarkers present.

The earlier a cancer can be detected, the sooner treatment can begin, and the better chance a patient has of survival.

The key to the breakthrough, according to Princeton's researchers, lies in a new nanomaterial they call D2PA. The nanomaterial, which was developed in Chou's lab, consists of a thin layer of gold nanostructures surrounded by glass pillars that are 60 nanometers in diameter. About 1,000 of the pillars can be laid side-by-side and still only be as wide as a human hair.

Each pillar, spaced 200 nanometers apart, is capped with a gold disk. Each pillar also is speckled with even smaller gold dots. The pillars boost the collection and transmission of light by a billion-fold, Princeton said.

The university noted that Chou is focused on using the new technology to detect early-stage breast and prostate cancers. He also is working with researchers at the Memorial Sloan-Kettering Cancer Center in New York to develop tests to detect proteins associated with early stage Alzheimer's disease.

More:

Researchers use nanotech to make cancer 3M times more detectable

Researchers Use Nanotech to Make Cancer 3 Million Times More Detectable

Posted on by

Scientists at Princeton University say they have used nanotechnology to make tests to detect diseases, like cancer and Alzheimer's disease, 3 million times more sensitive.

That means what researchers are calling a breakthrough in nanotechnology and medicine could enable doctors to detect these illnesses at much earlier stages, when they are more treatable.

"This advance opens many new and exciting opportunities ... in disease early detection and treatment," said Stephen Chou, a Princeton engineering professor, who led the research team. "You can have very early detection with our approach."

Princeton researchers used nanotechnology to improve a biological test called an immunoassay, which measures the concentration of a substance in a body fluid sample, and is used to find markers for cancers and Alzheimer's, in patients. The test produces a fluorescent glow when the disease is detected. The stronger the presence of the disease, the brighter the test glows.

However, if only faint, early-stage, traces of the disease are present, the glow can't be detected and the disease could be missed.

The Princeton researchers used nanotechnology to amplify the fluorescence, which gave them a 3-million-fold improvement in detection. It means the test now can detect disease with 3 million times fewer disease biomarkers present.

The earlier a cancer can be detected, the sooner treatment can begin, and the better chance a patient has of survival.

The key to the breakthrough, according to Princeton's researchers, lies in a new nanomaterial they call D2PA. The nanomaterial, which was developed in Chou's lab, consists of a thin layer of gold nanostructures surrounded by glass pillars that are 60 nanometers in diameter. About 1,000 of the pillars can be laid side-by-side and still only be as wide as a human hair.

Each pillar, spaced 200 nanometers apart, is capped with a gold disk. Each pillar also is speckled with even smaller gold dots. The pillars boost the collection and transmission of light by a billion-fold, Princeton said.

The university noted that Chou is focused on using the new technology to detect early-stage breast and prostate cancers. He also is working with researchers at the Memorial Sloan-Kettering Cancer Center in New York to develop tests to detect proteins associated with early stage Alzheimer's disease.

Read the original:

Researchers Use Nanotech to Make Cancer 3 Million Times More Detectable

Nanotechnology may aid diagnosis

Posted on by

A common type of lab test used in research and medicine can be made three million times more sensitive, raising hopes that certain cancers and Alzheimer's disease can be detected earlier.

That is the conclusion of new research by Princeton University engineers, published in the journal Analytical Chemistry, which describes an improved lab test that uses nanotechnology.

The test is called a fluorescent immunoassay, a laboratory staple for decades. It relies on antibodies that bind with specific proteins or biomarkers in a sample of fluid, such as blood or urine. The antibodies are "labeled" in such a way that they emit a fluorescent glow indicating that the target protein is present.

The Princeton researchers used an array of nano-antennas to amplify this type of fluorescence so that targeted proteins, such as those that may herald the presence of certain cancers, could be detected at much lower levels.

The antenna arrays consist of glass pillars measuring just 60 billionths of a meter in height, each capped with a tiny gold disk. The pillars also have smaller gold dots on their sides.

The system acts somewhat like the wooden body of a violin, which transmits the vibrations of the strings to the surrounding air, said senior author Stephen Y. Chou, a professor of electrical engineering at Princeton. "Without the body, you'd struggle to hear the sound," he said.

Chou and his colleagues evaluated their technology on fluid containing a standard lab protein called human immunoglobin G ordinarily detectable at a concentration of about one-billionth of a mole (a basic unit in chemistry) per liter. The team detected the protein at a concentration three million times lower.

The test could help diagnose Alzheimer's disease, which researchers try to detect by taking samples of cerebrospinal fluid, a relatively invasive procedure. Chou's technology, which detects much smaller concentrations in blood, "would be much easier and faster to use," said Yueming Li, a researcher at Memorial Sloan-Kettering Cancer Center who advised Chou on the research.

The group is conducting further research to detect biomarkers for specific diseases, such as breast and prostate cancers.

Tom Avril

See the original post:

Nanotechnology may aid diagnosis

Annals of Internal Medicine tip sheet for July 10, 2012, online issue

Posted on by

Public release date: 9-Jul-2012 [ | E-mail | Share ]

Contact: Abbey Anderson aanderson@acponline.org 215-351-2656 American College of Physicians

1. Free Curriculum Aims to Educate Internal Medicine Residents About Wasteful Health Care Spending

Developed by the American College of Physicians and the Alliance for Academic Internal Medicine, the New Curriculum is Part of ACP's Ongoing High-Value, Cost-Conscious Care Initiative

Economists warn that health care spending in the United States is rising at an unsustainable rate. To slow the rate of increase, while preserving high quality care, thought leaders in academic medicine suggest that clinicians focus on using medical interventions that provide good value. This means that clinicians should weigh potential benefits against potential harms and costs before initiating an intervention. As part of an ongoing initiative to promote high-value, cost-conscious care, the American College of Physicians (ACP) and the Alliance for Academic Internal Medicine (AAIM) developed a free curriculum to help train internal medicine residents about how to avoid overuse and misuse of tests and treatments that do not improve outcomes and may cause harms. The high-value, cost-conscious care curriculum is designed to engage internal medicine residents and faculty in small group activities organized around actual patient cases that require careful analysis of the benefits, harms, costs, and use of evidence-based, shared decision making. According to the study authors, the curriculum is important because physicians receive little specific training about identifying and eliminating wasteful treatment options. Since habits that are learned during residency training have been shown to stick with physicians throughout their professional careers, it is an optimal time to prepare physicians to become good stewards of health care resources. ACP-AAIM members and staff, program directors, associate program directors, a department chair, residency faculty, and internal medicine residents collaborated to develop the curriculum. It can be accessed for free at http://www.highvaluecarecurriculum.org,

2. Evidence Reveals Little Difference in Efficacy Between Intensive Insulin Therapies, Glucose Monitoring Approaches

Advances in intensive insulin therapy and glucose monitoring are designed to improve glycemic control and quality of life while limiting adverse effects such as hypoglycemia and weight gain. Currently, there are several therapies being heavily marketed to patients, but there is little objective evidence available to guide decision making about which therapy is best for the individual patient. Researchers reviewed published studies to evaluate how intensive insulin therapy (multiple daily injections versus insulin pump) or mode of blood glucose monitoring (self-monitoring versus real-time monitoring) affects outcomes in children and adults with type 1 or 2 diabetes. The researchers found that insulin pump and multiple-daily injections have similar effects on glycemic control and the incidence of severe hypoglycemia in children and adolescents with type 1 diabetes and in adults with type 2 diabetes. However, insulin pump yielded better satisfaction with diabetes treatment in children with type 1 diabetes, and better diabetes-specific quality-of-life in adults with type 1 diabetes. As for blood-glucose monitoring, real-time monitoring achieved a lower blood glucose level compared to self-monitoring. The researchers also found that real-time glucose monitoring was associated with a lower blood glucose level compared with multiple daily injection in individuals 18 years of age or younger, but the rate of severe hypoglycemia, weight gain, and quality of life did not seem to differ between intervention groups. Patients that used a sensor-augmented pump experienced greater reduction in blood glucose compared to multiple daily injection/self-monitoring use in individuals with type 1 diabetes. The researchers conclude that based on the evidence, physicians can use patient preference to guide treatment decisions for type 1 and type 2 diabetes.

###

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.

See original here:

Annals of Internal Medicine tip sheet for July 10, 2012, online issue

What is “concierge medicine” and how does it impact you?

Posted on by

Readmore: Local, News, Health, Consumer, Concierge Medicine, Doctors, Insurance Companies, Members only Practice, Private Practice, Doctor Patient Relationship, Donald Vanorden, Health Care System, Healthcare, Insurence, American Academy of Private Physicians, American Medical Association

If you're one of the millions of Americans who have received a letter from your doctor informing you they're changing things up to become a "members only" practice, you know the growth of so-called "concierge medicine."

A government commission recently found the number of such red-carpet practices has increased five-fold in the last six years.

Dr. Jennifer Chilek went into private practice eight years ago at Stone Creek Family Medicine in Montgomery, Texas, but, like so many doctors across the country, she's felt the pinch as overhead goes up and reimbursements go down.

"The insurance companies have handcuffed small practices," she says.

The only way to make ends meet was to bring in more patients, which in turn means less face time with your doctor.

"The health care system is destroying the doctor-patient relationship. I couldn't have kept going the way that it was," Chilek explains.

So this year Chilek joined an estimated 3,500 private practitioners who've switched to so-called concierge or boutique medicine, which has swept the nation the last decade.

Patients pay an annual fee from $600 to $5,000, even $20,000, and insurance is not accepted.

Chilek chose a newer, more affordable model called practice membership that works with your insurance.

See more here:

What is “concierge medicine” and how does it impact you?

BG Medicine, Inc. to Present at the JMP Securities Healthcare Conference

Posted on by

WALTHAM, Mass., July 9, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that it will present at the upcoming JMP Securities Healthcare Conference on Friday, July 13, 2012 at 11:30 a.m. Eastern Time. Eric Bouvier, President and CEO of the Company, will present an overview of BG Medicine. The corporate presentation will be available to the public through a webcast accessible by visiting: http://wsw.com/webcast/jmp18/bgmd/ or the "Investors" section of the Company's website at http://www.bg-medicine.com. Replays will be available for 30 days after the presentation.

About BG Medicine, Inc.

BG Medicine, Inc. (BGMD) is a life sciences company focused on the discovery, development and commercialization of novel cardiovascular diagnostics to address significant unmet medical needs, improve patient outcomes and contain healthcare costs. The Company's first commercialized product, the BGM Galectin-3TM test for use in patients with heart failure, is available in the United States and Europe. BG Medicine is also developing CardioSCORE, a blood test designed to identify individuals at high risk for near-term major cardiovascular events, such as heart attack and stroke. For additional information about BG Medicine, heart failure and galectin-3 testing, please visit http://www.bg-medicine.com and http://www.galectin-3.com.

The BG Medicine Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10352

See the article here:

BG Medicine, Inc. to Present at the JMP Securities Healthcare Conference

Primary Care To Be Job One For New Medical School

Posted on by

NORTH HAVEN

In a year, Quinnipiac University expects to open the third medical school in the state to help ease a dramatic shortage of primary care doctors and to create a new brand of physician a doctor comfortable in a collaborative team of professionals.

To outsiders, Quinnipiac might seem an unlikely place for one of the 18 new medical schools planned around the country. But those familiar with Quinnipiac's expansion, from regional college to higher-profile university, as well as its health-care focused programs see the medical school as a logical next step.

Dr. Bruce Koeppen, who was dean of academic affairs at the University of Connecticut School of Medicine when he read about Quinnipiac's plan, says his first reaction was: "Who do they think they are? There's no way they could possibly do this.'"

But within months Koeppen was named dean of Quinnipiac's nascent medical school and supervisor of the $100 million effort to get it built, staffed and accredited. He is particularly excited about building "a medical school from scratch" that will train physicians with the latest in facilities, curriculum and approach.

"We've hired people Many had wanted to make changes in the medical schools where they were and were frustrated that nothing happened. Here we have a clean slate and no barriers in the way," said Koeppen, whose office is not from the construction site.

The university is renovating a former Blue Cross Anthem buildling on its North Haven campus for the school, aimed at producing primary care physicians who are in short supply. Even in its design, the new school hopes to foster a team approach by ensuring that medical students and the students in other health programs cross paths and share common space.

In many schools, doctors are trained to be "the captain of the ship or the pilot of the airplane and everyone is supposed to obey them. There is a lot of evidence out there that you get better outcomes, better patient safety, if the individuals that are taking care of the patient are really working as a team," said Koeppen, 60.

"The analogy is a pit crew for NASCAR," Koeppen said. "Where you have a group of people with very specific talents and knowledge and expertise on the pit crew coming together to take care of the car."

The Frank H. Netter M.D. School of Medicine, as Quinnipiac's new school is called, is part of a wave of medical school development that began in the past decade, after a period from the early 1980s to 2000 when there were essentially no new medical schools.

See the original post here:

Primary Care To Be Job One For New Medical School

Liberty Announces Hall of Fame Class of 2012

Posted on by

From Liberty athletics:

LYNCHBURG, Va. Representatives from football, men's and women's basketball, wrestling and the men's track & field program will be among the next five members inducted into the Liberty Athletics Hall of Fame in September.

The five-member class, the fourth such to be inducted into the Liberty Athletics Hall of Fame, will be honored during special ceremonies surrounding Liberty's football match-up with Lehigh on Sept. 22 at Williams Stadium.

The five-member class includes Jesse Castro (wrestling), Mark Chafin (men's basketball), John Sanders (football), Sharon Snodgrass (women's basketball) and Ryan Werner (men's track & field).

The Liberty Athletics Hall of Fame induction ceremony will be held on Sept. 21 on the Club Pavilion level of the Williams Stadium Tower, while the five-member class will receive special recognition during the Lehigh game the evening following the ceremony.

The Liberty Athletics Hall of Fame celebrates the best of the best, honoring those who helped shape the face of Liberty Athletics. The Hall of Fame's now 22 members have each played a key role in helping Liberty grow from an NCCAA program in 1972 to its current status as a thriving NCAA Division I program today.

Jesse Castro

(Wrestling 1977-81)

See the article here:

Liberty Announces Hall of Fame Class of 2012

Liberty University's Upcoming Art Gallery Season Sure to Capture Gazes, Imagination

Posted on by

The Liberty University Art Gallery aims to become a cultural hub for the campus and the community.Lynchburg, VA (PRWEB) July 09, 2012 Thanks to the growth and expansion of Liberty University’s Department of Studio and Digital Arts, the campus has been graced with an array of stunning visual enhancements.For the 2012-13 academic year, SADA has a full art exhibition season lined up, promising to ...

Continue reading here:

Liberty University's Upcoming Art Gallery Season Sure to Capture Gazes, Imagination

Liberty Property Trust Hosts Second Quarter 2012 Results Conference Call

Posted on by

MALVERN, Pa., July 9, 2012 /PRNewswire/ --Liberty Property Trust (LRY) will host its second quarter results conference call on Tuesday, July 24, 2012, at 1:00 P.M., ET. The call can be accessed by dialing (888) 870-2815 and entering the passcode 98243676. The conference call will also be available live at http://www.libertyproperty.com in the "Investor Relations" section of the site. Liberty will issue a press release detailing results the same day before the market opens.

If you are unable to join the conference call, you may access the archived webcast, also in the Investor Relations section of the web site. In addition, a recording will be available telephonically until August 17, 2012 by dialing (855) 859-2056 and using the passcode 98243676.

Liberty Property Trust (LRY) is a leader in commercial real estate, serving customers in the United States and United Kingdom, through the development, acquisition, ownership and management of superior office and industrial properties. Liberty's 77 million square foot portfolio consists of 650 properties providing office, distribution and light manufacturing facilities to 1,700 tenants.

See the original post:

Liberty Property Trust Hosts Second Quarter 2012 Results Conference Call

Liberty Silver Corp. Successfully Completes First Phase of 2012 Drilling Program

Posted on by

TORONTO, ONTARIO--(Marketwire - July 9, 2012) - Liberty Silver Corp. (LSL.TO)(LBSV) ("Liberty Silver" or the "Company") is pleased to announce results of the first phase of its 2012 drilling program in the Trinity silver mining district in Pershing County, Nevada. Drilling was directed to the exploration of selected areas adjacent to the resource zone identified in the Company's 2011 NI 43-1012 technical report (the "Resource Area"), as well as confirmation of that resource.

Highlights

Bill Tafuri, President and COO, said, "We are extremely pleased with the results from phase one of our 2012 drilling program. Trinity is a large, high quality asset that provides us with a relatively low-risk opportunity to expand the known Resource, and also has high quality exploration targets. We are very excited about the potential revealed by the first phase of drilling."

PROGRAM HIGHLIGHTS

Eighteen vertical drill holes were completed to depths of up to 1,500 feet in rhyolite and underlying metasedimentry host rocks by reverse circulation for a total of (20,030) feet. Drilling tested parts of five (5) geographic domains in the vicinity of the southern end the Trinity open pit mine and the 43-101 Resource Area. Sixteen holes intercepted sample intervals greater than 1 opt silver ("Ag") with grades as high as 15 opt Ag. Sulfide zone samples contain up to 1.7 % lead ("Pb") and 1.6 % zinc ("Zn"). A map of the location of the drill holes can be found on the Company's website at: http://www.libertysilvercorp.com.

In addition to 18 holes drilled during phase 1 of the 2012 drilling program, approximately 395 holes were drilled during the period from 1982-2007, mainly by US Borax. While approximately 50 of these holes are widely spaced throughout the approximate 13 square-mile area of interest, the large majority are located within an approximate one square mile area centered on the Trinity open pit silver mine. Based on historical(1) and current assays, all holes contain anomalous silver throughout. The non-43-101-compliant average grade for all 413 holes is 0.70 opt Ag.

The following Table summarizes the oxide mineralization encountered in the drilling:

The Following Table summarizes the deeper sulfide mineralization as well as base metals of interest:

The three holes drilled in Domain 1, penetrated to depths of 1,040 to 1,120 ft and contain weakly anomalous Ag throughout. Very thin horizons of Ag at 1.2 to 5.1 opt Ag are found spatially associated with speculated fault zones at 635 to 700 ft depths.

Domain 2 (Holes A12-1, -2, -3 and -6) is located immediately southwest of the south end of the Trinity pit. Holes A12-1 and A12-6 host no oxide Ag above 0.5 opt but do contain sulfide Ag averaging 0.90 opt and 0.95 opt Ag, respectively with grades improving at depth. A12-2 contains 1.0 opt oxide Ag at a depth of 80 to 90 ft while A12-3 contains 0.77 opt oxide Ag from 105-115 ft deep.

Read more:

Liberty Silver Corp. Successfully Completes First Phase of 2012 Drilling Program

Liberty Shareholders Approve Debt Restructuring

Posted on by

TSX: LBE

TORONTO , July 9, 2012 /CNW/ - Liberty Mines Inc. today announced that it received approval at its annual meeting of shareholders to consolidate its credit facilities with Jien International Investment Limited (JIIL), and extend the terms to a new maturity date of June 30, 2017 .

Following shareholder approval and subject to the execution of a new loan agreement with JIIL in due course, the consolidated credit facility will have an outstanding principal amount of: (i) $48,914,849 and (ii) US$19,348,828 plus accrued interest to date. The credit facility bears interest at 10% per annum, which is secured against the assets of the Company, and no interest will be payable until June 30 , 2014. Related to the new maturity date and consolidated terms, JIIL has also agreed to expand the available credit facility by an additional $10,000,000 as well as continues to provide an available facility to address the preferred shares if redeemed prior to June 30, 2013 .

"Consolidating the credit facilities and extending the terms out five years was based on Liberty's five year business plan," said Chris Stewart , President & CEO of Liberty Mines. "This change allows us the opportunity to ramp up our production in Timmins so that we can generate some solid financial results to start repaying our debt. With the continued support of our major shareholder Jilin Jien, we have been able to execute our turnaround strategy for Liberty Mines and we are now focused on moving ahead with our plans for the Timmins operations."

At the annual meeting, Liberty shareholders also approved the election of Mr. Shu Wu , Mr. John Pinsent , Dr. Tao Li , Dr. Shu Zhang , Mr. Kim Oishi , Mr. Chris Stewart and Mr. James Xiang as directors of the Company. The directors bring a combination of mining, capital markets and public company experience.

Liberty shareholders also approved the nomination of BDO Dunwoody as the auditors for the Company.

Liberty has filed the full voting results of its annual meeting on SEDAR.

About Liberty Mines Inc. Liberty Mines Inc. is a mid-tier producer of nickel and is focused on the exploration, development and production of nickel, copper, cobalt and platinum group metals from its properties in Ontario, Canada . It owns and operates the only nickel concentrator in the Shaw Dome, a prospective nickel belt region near Timmins, Ontario. With a new management team in place, Liberty is focused on growth initiatives not only through a more aggressive exploration program on its current properties but also through potential acquisition or partnership opportunities beyond its core Timmins area projects.

See the original post:

Liberty Shareholders Approve Debt Restructuring

Liberty Energy Completes Assignment of Oil and Gas Assets in Texas

Posted on by

HOUSTON, July 9, 2012 (GLOBE NEWSWIRE) -- Liberty Energy Corp. (LBYE) ("Liberty" or "the Company") is pleased to announce the completion of its acquisition of over 1,000 acres in Bastrop, Caldwell and Eastland Counties, Texas.

The acquisition falls in line with the Company's strategy of growing shareholder value through acquiring assets in proven onshore oil and gas play within the US. The leases are considered to be highly prospective, with a mixture of work-over potential and exploration and development drilling.

The Company is working to finalize geological and geophysical work plans to be completed on the new leases. All of the new leases are considered to be low risk being positioned within proven, multiple payzone, producing counties. The Company also intends to work with existing partners to investigate and further develop the new and existing leases.

Ian Spowart, Chief Executive Officer, commented: "Whilst our strategy is to expand aggressively, we are always looking to maximize returns and increase shareholder value. The new acreage is a great addition to our existing portfolio and we look forward to providing further information on geological and geophysical work to be carried out on the new leases in due course."

Bastrop County

Bastrop County is located in South Texas. The majority of production in Bastrop is attributed to the Austin Chalk and Navarro formations.1 The county presently houses over 1,700 wells and over 170 operators including; Texas Vanguard Oil Company, Chalker Operating Inc. and Petro-Gas Inc.2 The Eagle Ford Shale formation is in the oil maturity window and is present in Bastrop County. The play is 50 miles wide and an average of 250 feet thick at a depth between 4,000 and 12,000 feet. The oil reserves are estimated at 3 billion barrels of oil (BBO) with potential output of 420,000 barrels of oil per day (bopd).1 Major producers in the county include Anadarko, Exxon-XTO and PetroHawk. Liberty will, under the terms of the LOI, acquire five leases comprising approximately 630 highly prospective acres within the county.

Caldwell County

There are four main pay zones within Caldwell County, the Sepertine, Dale Lime, Austin Chalk and Edwards. There are currently 385 operators (including Eagle Ford Oil Co., Inc., Luling O&G LLC and Texas Petroleum Investment Co.) and nearly 9,000 wells in Caldwell County.3 From March 2010 to March 2011 the county produced over 1 million barrels of oil (MMBO).4 Liberty will, under the terms of the LOI, acquire two leases comprising approximately 300 greatly prospective acres within the county.

Eastland County

In addition to having the Marble Falls, Duffer and Mississippian formations, Eastland County is the westernmost extension of the Barnett Shale play and can be considered as part of the active Barnett Shale play area.5 The Bend Arch has had a significant effect on the Barnett Shale in regards to regarding its burial history and geo-thermal makeup. The Barnett is the source rock for the hydrocarbons produced from many of the shallower zones over the Bend Arch such as the Marble Falls and Duffer. There are currently 893 operators (including North Ridge Corporation, Sun Expl. & Prod. Co.-Abilene and B & B Oil, Inc.) and over 10,900 wells in Eastland County.2 Using a geology-based assessment methodology, the U.S. Geological Survey estimated a mean of 26.7 trillion cubic feet (TCF) of undiscovered natural gas, a mean of 98.5 MMBO undiscovered oil, and a mean of 1.1 billion barrels of undiscovered natural gas liquids (BBNGL) in the Bend Arch-Fort Worth Basin Province.6 Liberty will, under the terms of the LOI, acquire one lease comprising approximately 110 considerably prospective acres within the county.

Excerpt from:

Liberty Energy Completes Assignment of Oil and Gas Assets in Texas

Ron Paul Takes Up Internet Freedom

Posted on by

Libertarians say they have an issue that's perfect for the 21st CenturyInternet freedom. And many of them are counting on libertarian hero Ron Paul and his son, Republican Sen. Rand Paul of Kentucky, to carry the theme into the future.

The two Pauls are expected to place their personal imprimatur on the Internet issue soon. Campaign for Liberty, a libertarian group supported by Ron Paul, has already issued a manifesto opposing more government regulation of the Internet. "Around the world, the real threat to Internet frreedom comes not from bad people or inefficient marketswe can and will always route around thembut from governments' foolish attempts to manage and control innovation," the Campaign for Liberty manifesto says.

[Read the U.S. News Debate: Should There Be an International Treaty on Cyberwarfare?]

The group also plans to continue pushing for auditing and eventually ending the Federal Reserve, which has for many years been a goal of Ron Paul, the GOP congressman from Texas who has been seeking the Republican presidential nomination this year.

The Internet issue is expected to be particularly popular among young people, who have been a big part of Ron Paul's grass-roots support system.

In a related development, Libertarian Party presidential nominee Gary Johnson, the former two-term governor of New Mexico, is asking supporters to demand that he be included in national presidential polls. This is part of his campaign to push his way into the presidential debates this fall. He needs 15 percent in a series of national polls in order for him to appear side by side with President Obama and presumptive GOP nominee Mitt Romney. A recent Gallup poll gave Johnson only 3 percent nationally; other surveys have excluded him from consideration.

Johnson says his philosophy is simple: he is "pro-choice with regard to everything."

Ken Walsh covers the White House and politics for U.S. News. He writes a daily blog, "Ken Walsh's Washington," and is the author of "The Presidency" column for the U.S. News Weekly. He can be reached at kwalsh@usnews.com and on Facebook and Twitter.

Read the original:

Ron Paul Takes Up Internet Freedom

Gene Discovered By Scientists Linked To Facial Abnormalities

Posted on by

Editor's Choice Main Category: Genetics Article Date: 09 Jul 2012 - 12:00 PDT

Current ratings for: Gene Discovered By Scientists Linked To Facial Abnormalities

The finding was published in The American Journal of Human Genetics and was conducted by Dr. Hyung-Goo Kim, molecular geneticist at the Medical College of Georgia at Georgia Health Sciences University and his team.

The researchers discovered the PHG21A mutated gene in patients with Potocki-Shaffer syndrome, a rare disorder that can result in significant abnormalities, like a small head and chin as well as intellectual disability.

The researchers conducted experiments in zebrafish, which developed similar head and brain abnormalities to those found in humans and discovered that their findings were confirmed when they suppressed the PHF21A gene in zebrafish.

Dr. Kim explained:"With less PHF21A, brain cells died, so this gene must play a big role in neuron survival."

To reconfirm their finding, the team inserted the gene back into the malformed fish, which subsequently became normal. The gene was also found in the craniofacial area of normal mice. Even though it is impossible to cure humans just by re-inserting the normal gene as is possible in zebrafish, the researchers believe that their finding will, in the future, allow genetic screening and possibly early intervention during fetal development, as well as treatments to increase PHF21A levels. In addition, the finding provides more insight into a better understanding of face, skull and brain formation.

The team focused on the gene when they used a distinctive chromosomal break found in patients with Potocki-Shaffer syndrome as a starting point. Chromosomes, i.e. packages of DNA and protein, are not supposed to break. However, when they do, they can damage nearby genes. Co-author of the study, Dr. Lawrence C. Layman, who is Chief of the MCG Section of Reproductive Endocrinology, Infertility and Genetics, explained: "We call this breakpoint mapping and the breakpoint is where the trouble is."

Damaged genes can no longer retain their optimum function. In PHF21A's case for instance the functionality is reduced to about half of the norm.

Layman continues: "When you see the chromosome translocation, you don't know which gene is disrupted. You use the break as a focus then use a bunch of molecular techniques to zoom in on the gene."

Here is the original post:

Gene Discovered By Scientists Linked To Facial Abnormalities

The health of America

Posted on by

Health care reforms put forward by U.S. President Barack Obama have passed constitutional scrutiny. In an anxiously awaited, bitterly divided 5-4 ruling, the U.S. Supreme Court ruled the week before last that the bulk of the bill, put into law in 2010, can go into effect.

The decision upholds the most important piece of social legislation put forward in the United States for decades, but in a sad commentary on the static perspective of many Americans, the overwhelming majority of the commentaries and analyses have focused on the politics of the decision, rather than on its impact on health care in the country.

Experts and specialists have long called for reform of the U.S. health care system. President Bill Clinton tried to implement change in his first term in office nearly two decades ago, but that effort failed miserably. By the time Mr. Obama took office, the U.S. was spending 17.6 percent of its GDP on health care more than any other developed country an amount that had steadily risen from 12.4 percent in 1990.

While U.S. politicians claim that theirs is the best health care system in the world, statistics tell another story: Average life expectancy in the U.S. is below the Organization for Economic Cooperation and Development (OECD) average; its infant mortality rate is 43rd among nations; the U.S. has the highest rate of obesity among the 34 developed nations, a fact that anticipates more disease, such as heart disease and diabetes, later in life; health spending per person is more than twice that of other wealthy nations that have universal health care; and perhaps most damning of all, an estimated 50 million people do not have health insurance, while it is reckoned that half of all bankruptcy filings in the U.S. are the result of health care bills.

Yet, almost immediately after Mr. Obama signed the Patient Protection and Affordable Care Act (ACA), more than half the state governments in the U.S. filed suits to overturn the law. They alleged that the law's mandate that individuals buy health insurance or pay a fine was an unconstitutional assertion of federal government power that it could not force individuals to take part in economic activity. They also charged that the law's expansion of Medicaid a program for low-income individuals was coercive insofar as a state's failure to abide by the new rules would forfeit federal Medicaid funds.

On June 28, the last day of the court's term, the decision came down. As anticipated, it was a 5-4 decision. Surprisingly, the swing vote was Chief Justice John Roberts, a conservative who was anticipated to have opposed the law.

Instead, he wrote the majority opinion that concluded that while the government could not compel people to engage in economic activity such as mandating them to buy insurance it could tax people who did not. (That the government preferred to not call its actions "a tax" was irrelevant; long-standing judicial principles urge judges to find reasons to support legislative action.) A 7-2 majority struck down the expansion of the Medicaid program, agreeing that such action was overly coercive.

The decision prompted predictable responses. Republicans, who have opposed the law since it was first proposed (even though they backed individual components such as the mandate during the Clinton effort), continued to insist that it was a socialist program that constituted government over-reach, would hurt the economy and would harm the provision of health care in the U.S.

Leaders of the party, including Mr. Mitt Romney, the presumed GOP presidential candidate who will challenge Mr. Obama in the November elections, have vowed to repeal the law on the first day of the new administration.

On the other side of the aisle, Democrats exulted in the constitutionality of Mr. Obama's signature legislative proposal for his first term in office.

Read the original here:

The health of America